Radiation as Effective as Surgery for Prostate Cancer
A recent study has shown that stereotactic radiation therapy for prostate cancer achieves similar results to surgery in controlling the disease, with fewer side effects. After an average follow-up of eight years, the rates of cancer recurrence-free survival were 91% for patients who received radiation therapy compared to 84% for those who underwent surgery. The study involved 123 patients, most of whom had low or intermediate-risk cancer. The treatment focuses on delivering radiation directly to the prostate while minimizing exposure to healthy tissues, leading to excellent outcomes and less impact on sexual function, although the study was affected by the COVID-19 pandemic, which reduced the number of participants.
Notice: This Is an AI-Generated Summary
Comments (0)